NO20045071L - Fremgangsmate for fremstilling av krystaller ut i fra aktive legemiddelvirkestoffer, krystaller oppnadd derav og deres anvendelse i farmasoytiske formuleringer - Google Patents

Fremgangsmate for fremstilling av krystaller ut i fra aktive legemiddelvirkestoffer, krystaller oppnadd derav og deres anvendelse i farmasoytiske formuleringer

Info

Publication number
NO20045071L
NO20045071L NO20045071A NO20045071A NO20045071L NO 20045071 L NO20045071 L NO 20045071L NO 20045071 A NO20045071 A NO 20045071A NO 20045071 A NO20045071 A NO 20045071A NO 20045071 L NO20045071 L NO 20045071L
Authority
NO
Norway
Prior art keywords
crystals
pharmaceutical formulations
preparation
obtained therefrom
active ingredients
Prior art date
Application number
NO20045071A
Other languages
English (en)
Inventor
Detlef Grawe
Peter Hosel
Uwe Mueller
Annette Eichardt
Hagen Gerecke
Sabine Gliesing
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20045071L publication Critical patent/NO20045071L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det beskrives en fremgangsmåte for fremstilling av krystaller av legemiddelaktivbestanddel hvis gjennomsnittlige partikkelstørrelse ligger innen et på forhånd gitt område og hvis maksimale partikkelstørrelse ikke overskrider en på forhånd gitt verdi, hvorved en overmettet oppløsning under krystalliseringen underkastes en våtoppmaling ved hjelp av en innretning for våtoppmaling, hvorved det oppnås en primærkornsuspensjon.Det beskrives videre de krystaller som oppnås ved denne metode samt farmasøytiske formuleringer inneholdende krystallene.
NO20045071A 2002-04-23 2004-11-22 Fremgangsmate for fremstilling av krystaller ut i fra aktive legemiddelvirkestoffer, krystaller oppnadd derav og deres anvendelse i farmasoytiske formuleringer NO20045071L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10218106A DE10218106A1 (de) 2002-04-23 2002-04-23 Verfahren zum Herstellen von Kristallen von Arzneimittelwirkstoffen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
PCT/EP2003/004153 WO2003090721A2 (de) 2002-04-23 2003-04-22 Verfahren zur herstellung von kristallen von arzneimittelwirkstoffen und deren verwendung in pharmazeutischen formulierungen

Publications (1)

Publication Number Publication Date
NO20045071L true NO20045071L (no) 2005-01-21

Family

ID=29264786

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045071A NO20045071L (no) 2002-04-23 2004-11-22 Fremgangsmate for fremstilling av krystaller ut i fra aktive legemiddelvirkestoffer, krystaller oppnadd derav og deres anvendelse i farmasoytiske formuleringer

Country Status (16)

Country Link
US (1) US20030215516A1 (no)
EP (1) EP1523302A2 (no)
JP (1) JP2005535577A (no)
KR (1) KR20050003388A (no)
CN (1) CN1812767A (no)
AU (1) AU2003232490A1 (no)
BR (1) BR0309358A (no)
CA (1) CA2480130A1 (no)
DE (1) DE10218106A1 (no)
IL (1) IL163984A0 (no)
MX (1) MXPA04010466A (no)
NO (1) NO20045071L (no)
PL (1) PL371518A1 (no)
RU (1) RU2004134321A (no)
WO (1) WO2003090721A2 (no)
ZA (1) ZA200409398B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI415603B (zh) * 2005-05-20 2013-11-21 Merck Sharp & Dohme １，８－辛二醯基苯胺羥胺酸（ｓｕｂｅｒｏｙｌａｎｉｌｉｄｅ ｈｙｄｒｏｘａｍｉｃ ａｃｉｄ）之調配物及其製配方法
US20090087492A1 (en) * 2006-03-14 2009-04-02 Merck & Co., Inc. Processes and Apparatuses for the Production of Crystalline Organic Microparticle Compositions by Micro-Milling and Crystallization on Micro-Seed and Their Use
DE102010003711B4 (de) * 2010-04-08 2015-04-09 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoffpartikel
CA2947459A1 (en) 2014-05-13 2015-11-19 Akzo Nobel Chemicals International B.V. Process to crystallize chelating agents
CN108031142A (zh) * 2017-12-13 2018-05-15 上海合全药物研发有限公司 一种简化的利用湿磨来制备大量微晶种的装置及方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB838654A (en) * 1956-02-08 1960-06-22 Upjohn Co Steroids and the production thereof
US3226389A (en) * 1962-01-04 1965-12-28 Du Pont 11,11,12,12-tetracyano-naphtho-2,6-quinodimethan and its anion-radical salts
CH627449A5 (de) * 1977-03-25 1982-01-15 Hoffmann La Roche Verfahren zur herstellung von mikrokristallinem vitamin a-acetat, sowie von trockenen, frei-fliessenden praeparaten, in welchen vitamin a-acetat in mikrokristalliner form vorliegt.
DE2801705A1 (de) * 1978-01-16 1979-07-19 Metallgesellschaft Ag Verfahren zur gewinnung von kaliumchlorid
DE3014160A1 (de) * 1979-04-16 1980-10-30 Lummus Co Kristallisationsverfahren
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
US4997637A (en) * 1989-05-09 1991-03-05 Occidental Chemical Corporation Digestive crystallizing process and apparatus for purification of KC1
FR2668945B1 (fr) * 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
DE4143631A1 (de) * 1991-05-30 1998-04-16 Dynamit Nobel Ag Zerkleinerung von pulverförmigen Initialsprengstoffen
DE4244466C2 (de) * 1992-12-24 1995-02-23 Pharmatech Gmbh Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten

Also Published As

Publication number Publication date
JP2005535577A (ja) 2005-11-24
MXPA04010466A (es) 2004-12-13
WO2003090721A2 (de) 2003-11-06
PL371518A1 (en) 2005-06-27
KR20050003388A (ko) 2005-01-10
DE10218106A1 (de) 2003-11-20
CA2480130A1 (en) 2003-11-06
IL163984A0 (en) 2005-12-18
EP1523302A2 (de) 2005-04-20
CN1812767A (zh) 2006-08-02
BR0309358A (pt) 2005-02-22
ZA200409398B (en) 2006-06-28
AU2003232490A1 (en) 2003-11-10
RU2004134321A (ru) 2005-10-10
US20030215516A1 (en) 2003-11-20
WO2003090721A3 (de) 2005-02-24

Similar Documents

Publication Publication Date Title
NO20045073L (no) Fremgangsmate for fremstilling av krystaller, derved oppnaelige krystaller og deres anvendelse i farmasoytiske formuleringer
CA2360647A1 (en) Fast dispersing dosage forms free of gelatin
WO2003040144A3 (en) Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
ES2065499T3 (es) Alcohol sacarido cristalino que contiene compuesto farmaceutico particulado uniformemente disperso.
NO164817B (no) Fremgangsmaate til fremstilling av tofasede, nifedipinholdige, legemiddeltilberedninger.
BR0009176A (pt) Partìcula granular, forma de dosagem, métodopara preparar uma partìcula granular, misturaseca, e, formulação granular
WO2002074247A3 (en) Pharmaceutical formulations for sustained release
YU49202A (sh) Benzazolski derivati i njihova upotreba kao modulatora jnk
NO20035210D0 (no) 2-anilino-pyrimidinderivater som cyklinavhengige kinaseinhibitorer
WO2004037193A3 (en) Chromones and chromone derivatives and uses thereof
MD2447F2 (en) Pharmaceutical composition, use thereof and methods of treatment of cephalalgia, migraine, sickness and vomiting
HUP0100520A1 (hu) Csontfelszívódást és sejtösszenövést gátló új szulfonamidszármazékok
CA2330480A1 (en) Controlled release formulation of divalproex sodium
JPH0395178A (ja) 方法
DK160533B (da) Fremgangsmaade til fremstilling af en fast, bismuthholdig komposition og fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende den saaledes fremstillede komposition
IL163986A0 (en) Method for producting steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations
WO2003090721A3 (de) Verfahren zur herstellung von kristallen von arzneimittelwirkstoffen und deren verwendung in pharmazeutischen formulierungen
Marañón Variations in seed size and germination in three Aegilops species
UY25575A1 (es) Procedimiento para preparar forma termodinamicamente estable del acido (r)-3-[[(4-fluorofenil)sulfonil]amino]-1,2,3,4-tetrahidro-9h-carbazol-9-propanoico (ramatroban)
EP3511006A1 (en) Composition for preventing, improving or treating hair loss comprising deoxycholic acid as active ingredient
JP6427788B2 (ja) 芳香環系を有する有機酸アミドの改良された粉末配合物
JPH1156299A (ja) ビタミン群含有加工食品
AU2006307886A1 (en) Micronised azodicarbonamide, the preparation and use thereof
US20180064683A1 (en) Composition for promoting hair growth and/or hair restoration containing psoralidin
WO2003059244A3 (fr) Composition cosmetique contenant une huile extraite de graines de murumuru

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application